South Korea regulator says Samsung BioLogics intentionally breached accounting rules
South Korea’s top financial regulator on Wednesday said it found Samsung BioLogics Co Ltd intentionally breached accounting rules in inflating the company’s value ahead of its 2016 stock exchange listing.
